ONCTERNAL THERAPEUTICS, INC. RESTRICTED STOCK PURCHASE AGREEMENTRestricted Stock Purchase Agreement • April 8th, 2019 • GTX Inc /De/ • Pharmaceutical preparations • California
Contract Type FiledApril 8th, 2019 Company Industry JurisdictionTHIS RESTRICTED STOCK PURCHASE AGREEMENT (“Agreement”) is made as of December 14, 2017, by and between ONCTERNAL THERAPEUTICS, INC., a Delaware corporation (the “Company”) and Richard G. Vincent (the “Purchaser”).
ONCTERNAL THERAPEUTICS, INC. RESTRICTED STOCK PURCHASE AGREEMENTRestricted Stock Purchase Agreement • April 8th, 2019 • GTX Inc /De/ • Pharmaceutical preparations • California
Contract Type FiledApril 8th, 2019 Company Industry JurisdictionTHIS RESTRICTED STOCK PURCHASE AGREEMENT (“Agreement”) is made as of May 9, 2018, by and between ONCTERNAL THERAPEUTICS, INC., a Delaware corporation (the “Company”) and Charles Theuer, M.D., Ph.D. (the “Purchaser”).
ONCTERNAL THERAPEUTICS, INC. RESTRICTED STOCK PURCHASE AGREEMENTRestricted Stock Purchase Agreement • April 8th, 2019 • GTX Inc /De/ • Pharmaceutical preparations • California
Contract Type FiledApril 8th, 2019 Company Industry JurisdictionTHIS RESTRICTED STOCK PURCHASE AGREEMENT (“Agreement”) is made as of May 22, 2017, by and between ONCTERNAL THERAPEUTICS, INC., a Delaware corporation (the “Company”) and Richard Vincent (the “Purchaser”).
ONCTERNAL THERAPEUTICS, INC. RESTRICTED STOCK PURCHASE AGREEMENTRestricted Stock Purchase Agreement • April 8th, 2019 • GTX Inc /De/ • Pharmaceutical preparations • California
Contract Type FiledApril 8th, 2019 Company Industry JurisdictionTHIS RESTRICTED STOCK PURCHASE AGREEMENT (“Agreement”) is made as of December 14, 2017, by and between ONCTERNAL THERAPEUTICS, INC., a Delaware corporation (the “Company”) and William R. LaRue (the “Purchaser”).